News
News | 04 November 2026

Bayer raises 2026 outlook as pharma growth accelerates

While Pharmaceuticals gathered momentum, Crop Science and Consumer Health continued to perform in line with their respective targets despite challenging market conditions

News
News | 04 November 2026

Pfizer posts strong Q3 results raising 2026 forecast as new products drive growth

A major growth driver was Pfizer's launched and acquired product portfolio, which recorded a striking 32% year-over-year operational revenue increase.

News
News | 04 November 2026

Cambrex pumps $120 million into Iowa facility to boosts drug manufacturing capacity by 25%

The project will add 160,000 litres of manufacturing capacity, increasing the facility's total capacity by approximately 25% to nearly one million litres

News
News | 03 November 2026

Akums posts 168% jump in Q2 profit as revenue surges 32% & EBITDA more than doubles

Akums has expanded beyond pharmaceutical manufacturing by acquiring Oriflame India's manufacturing business for Rs 56 crore

News
News | 03 November 2026

Thyrocare enters pregnancy testing market as it launches India’s first home kit

The diagnostics major has also roped in actor Yami Gautam Dhar as the brand ambassador for the new product

News
News | 03 November 2026

Adalvo acquires Enzene’s romiplostim biosimilar programme to strengthens global biosimilars push

Deal marks a strategic shift for Enzene towards a focused global CDMO business

News
News | 03 November 2026

Major TRANSFORM II trial finds sirolimus-coated balloon matches drug-eluting stents in coronary artery disease

One of the key findings was the low rate of bailout stenting in the SCB group

News
News | 03 November 2026

Wockhardt Q2 revenue jumps 24% to Rs 969 crore; H1 growth hits 25%

EBITDA for Q2 FY27 stood at Rs 165 crore, marginally higher than Rs 160 crore in Q2 FY26

News
News | 03 November 2026

Teva pulls plug on Phase 2 trial of experimental MSA drug post futility analysis

Emrusolmin is designed to target alpha-synuclein aggregation, a key disease mechanism believed to contribute to MSA

News
News | 03 November 2026

Granules India reports 39% surge in Q2 FY27 PAT to Rs. 182 Cr

Operational revenue grew 20.3% YoY to a record Rs. 1,560 crore

News
News | 03 November 2026

Zydus Wellness consolidated net sales up by 74.6% in Q2 FY27

Nutralite achieved robust, double-digit growth across its portfolio

News
News | 03 November 2026

Shilpa CDMO to invest $50 million in commercial peptide manufacturing

First commercial line comes online in December 2026 as CDMO scales capacity for GLP-1s and next-generation complex peptides

News
News | 02 November 2026

Sun Pharma Q2 net profit jumps to Rs 3,162 Cr; revenue rises 11.8% to Rs 16,100 Cr

Sun Pharma invested Rs 778.4 crore in research and development during the quarter, equivalent to 4.8% of sales

News
News | 02 November 2026

Spektus Pharma and GEBRO strike global deal to commercialise twice-daily pain drug ActraFlex

Under the agreement, the companies will divide global commercialisation responsibilities across key international markets

News
News | 02 November 2026

Thyrocare posts 25.1% revenue growth in Q2FY27

PAT jumps 25.7% to Rs 60.2 crore

News
News | 02 November 2026

CORONA Remedies Q2 FY27 revenue jumps 22% to Rs. 441 Cr

The impressive 22% growth rate significantly outpaces the broader Indian Pharmaceutical Market averages

News
News | 02 November 2026

Dr. Reddy’s bags tentative USFDA nod for twice-yearly HIV injectable lenacapavir across 120 nations

The approval was granted under the U.S. FDA’s President’s Emergency Plan for AIDS Relief (PEPFAR) program

News
News | 31 October 2026

Ind-Swift Laboratories’ Q2 FY27 revenue jumps 50% & operating EBITDA fivefold

The performance reflects the benefits of the company's strategic transition from an active pharmaceutical ingredients (API) manufacturer to a finished dosage formulations (FDF) player

News
News | 31 October 2026

RPG Life Sciences crosses Rs 200-crore quarterly revenue milestone as it posts 16.5% growth in Q2

The company's flagship brand, Naprosyn, also crossed the Rs 100-crore sales milestone, marking another significant achievement

Startup

Digitization

Collaborative models are practical way to build capability in biologics: Manoj Kumar Panicker, Cytiva and Dr. Sanjib Banerjee, Veeda Lifesciences
Collaborative models are practical way to build capability in biologics: Manoj Kumar Panicker, Cytiva and Dr. Sanjib Banerjee, Veeda Lifesciences
(L-R) Manoj Kumar Panicker, General Manager, South Asia, Cytiva and Dr. Sanjib Banerjee, Chief Operating Officer (Biopharma Services), Veeda Lifesciences.